Common risk factors for heart failure and cancer
WC Meijers, RA de Boer - Cardiovascular research, 2019 - academic.oup.com
Cardiovascular (CV) disease and cancer are the leading causes of death., Over the last
decades, it has been appreciated that both CV disease and cancer are more common in …
decades, it has been appreciated that both CV disease and cancer are more common in …
Drug repurposing in cancer
L Sleire, HE Førde, IA Netland, L Leiss, BS Skeie… - Pharmacological …, 2017 - Elsevier
Cancer is a major health issue worldwide, and the global burden of cancer is expected to
increase in the coming years. Whereas the limited success with current therapies has driven …
increase in the coming years. Whereas the limited success with current therapies has driven …
Prevention and early detection of prostate cancer
Prostate cancer is a common malignancy in men and the worldwide burden of this disease
is rising. Lifestyle modifications such as smoking cessation, exercise, and weight control …
is rising. Lifestyle modifications such as smoking cessation, exercise, and weight control …
Cancer and heart disease: associations and relations
RA de Boer, WC Meijers, P van der Meer… - European journal of …, 2019 - Wiley Online Library
Emerging evidence supports that cancer incidence is increased in patients with
cardiovascular (CV) disease and heart failure (HF), and patients with HF frequently die from …
cardiovascular (CV) disease and heart failure (HF), and patients with HF frequently die from …
A review of resveratrol as a potent chemoprotective and synergistic agent in cancer chemotherapy
Background: Cancer has become a major disease endangering human health around the
world. Conventional chemotherapy suffers from many side effects including pain …
world. Conventional chemotherapy suffers from many side effects including pain …
Immune contexture, immunoscore, and malignant cell molecular subgroups for prognostic and theranostic classifications of cancers
E Becht, NA Giraldo, C Germain, A de Reyniès… - Advances in …, 2016 - Elsevier
The outcome of tumors results from genetic and epigenetic modifications of the transformed
cells and also from the interactions of the malignant cells with their tumor microenvironment …
cells and also from the interactions of the malignant cells with their tumor microenvironment …
Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds
Highlights•De novo anticancer drug discovery is challenging and repurposing in oncology is
a promising field.•Drug repositioning increasingly emerges as faster, cheaper and …
a promising field.•Drug repositioning increasingly emerges as faster, cheaper and …
Role of COX-2/PGE2 mediated inflammation in oral squamous cell carcinoma
WHS Nasry, JC Rodriguez-Lecompte, CK Martin - Cancers, 2018 - mdpi.com
A significant amount of research indicates that the cyclooxygenase/prostaglandin E2 (PGE2)
pathway of inflammation contributes to the development and progression of a variety of …
pathway of inflammation contributes to the development and progression of a variety of …
[PDF][PDF] Resveratrol in cancer chemotherapy: Is it a preventer, protector, or fighter
Malignant tumors, another name for cancerous diseases, are a serious public health
concern that not only causes patients to suffer excruciating pain, but also place a significant …
concern that not only causes patients to suffer excruciating pain, but also place a significant …
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial
N Joharatnam-Hogan, F Cafferty, R Hubner… - The lancet …, 2019 - thelancet.com
Background Preclinical, epidemiological, and randomised data indicate that aspirin might
prevent tumour development and metastasis, leading to reduced cancer mortality …
prevent tumour development and metastasis, leading to reduced cancer mortality …